|
1
|
Chen AY, Jemal A and Ward EM: Increasing
incidence of differentiated thyroid cancer in the United States,
1988–2005. Cancer. 115:3801–3807. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yu W, Wang J, Ma L, Tang X, Qiao Y, Pan Q,
Yu Y and Sun F: CD166 plays a pro-carcinogenic role in liver cancer
cells via inhibition of FOXO proteins through AKT. Oncol Rep.
32:677–683. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hoshino Y, Nishida J, Katsuno Y, Koinuma
D, Aoki T, Kokudo N, Miyazono K and Ehata S: Smad4 decreases the
population of pancreatic cancer-initiating cells through
transcriptional repression of ALDH1A1. Am J Pathol. 185:1457–1470.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Beck B and Blanpain C: Unravelling cancer
stem cell potential. Nat Rev Cancer. 13:727–738. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Xiao J, Mu J, Liu T-R and Xu H: Dig the
root of cancer: Targeting cancer stem cells therapy. J Med Discov.
2:JMD17003. 2017.doi: 10.24262/jmd.2.2.17003.
|
|
6
|
Hermann PC, Huber SL, Herrler T, Aicher A,
Ellwart JW, Guba M, Bruns CJ and Heeschen C: Distinct populations
of cancer stem cells determine tumor growth and metastatic activity
in human pancreatic cancer. Cell Stem Cell. 1:313–323. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li H and Tang DG: Prostate cancer stem
cells and their potential roles in metastasis. J Surg Oncol.
103:558–562. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pece S, Tosoni D, Confalonieri S, Mazzarol
G, Vecchi M, Ronzoni S, Bernard L, Viale G, Pelicci PG and Di Fiore
PP: Biological and molecular heterogeneity of breast cancers
correlates with their cancer stem cell content. Cell. 140:62–73.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sullivan JP and Minna JD: Tumor
oncogenotypes and lung cancer stem cell identity. Cell Stem Cell.
7:2–4. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhu L and Xu PC: Downregulated LncRNA-ANCR
promotes osteoblast differentiation by targeting EZH2 and
regulating Runx2 expression. Biochem Biophys Res Commun.
432:612–617. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nakagawa T, Endo H, Yokoyama M, Abe J,
Tamai K, Tanaka N, Sato I, Takahashi S, Kondo T and Satoh K: Large
noncoding RNA HOTAIR enhances aggressive biological behavior and is
associated with short disease-free survival in human non-small cell
lung cancer. Biochem Biophys Res Commun. 436:319–324. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xing M: BRAF mutation in thyroid cancer.
Endocr Relat Cancer. 12:245–262. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li R, Zhang L, Jia L, Duan Y, Li Y, Bao L
and Sha N: Long non-coding RNA BANCR promotes proliferation in
malignant melanoma by regulating MAPK pathway activation. PLoS One.
9:e1008932014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jiang W, Zhang D, Xu B, Wu Z, Liu S, Zhang
L, Tian Y, Han X and Tian D: Long non-coding RNA BANCR promotes
proliferation and migration of lung carcinoma via MAPK pathways.
Biomed Pharmacother. 69:90–95. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Flockhart RJ, Webster DE, Qu K,
Mascarenhas N, Kovalski J, Kretz M and Khavari PA: BRAFV600E
remodels the melanocyte transcriptome and induces BANCR to regulate
melanoma cell migration. Cancer Res. 73 (Suppl 8):LB–248. 2013.
View Article : Google Scholar
|
|
17
|
Gupta RA, Shah N, Wang KC, Kim J, Horlings
HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, et al: Long
non-coding RNA HOTAIR reprograms chromatin state to promote cancer
metastasis. Nature. 464:1071–1076. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xia M, Yao L, Zhang Q, Wang F, Mei H, Guo
X and Huang W: Long noncoding RNA HOTAIR promotes metastasis of
renal cell carcinoma by up-regulating histone H3K27 demethylase
JMJD3. Oncotarget. 8:19795–19802. 2017.PubMed/NCBI
|
|
19
|
Yang F, Bi J, Xue X, Zheng L, Zhi K, Hua J
and Fang G: Up-regulated long non-coding RNA H19 contributes to
proliferation of gastric cancer cells. FEBS J. 279:3159–3165. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yang C, Li X, Wang Y, Zhao L and Chen W:
Long non-coding RNA UCA1 regulated cell cycle distribution via CREB
through PI3-K dependent pathway in bladder carcinoma cells. Gene.
496:8–16. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Esteller M: Non-coding RNAs in human
disease. Nat Rev Genet. 12:861–874. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lan X, Zhang H, Wang Z, Dong W, Sun W,
Shao L, Zhang T and Zhang D: Genome-wide analysis of long noncoding
RNA expression profile in papillary thyroid carcinoma. Gene.
569:109–117. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gibb EA, Brown CJ and Lam WL: The
functional role of long non-coding RNA in human carcinomas. Mol
Cancer. 10:382011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang C, Yan G, Zhang Y, Jia X and Bu P:
Long non-coding RNA MEG3 suppresses migration and invasion of
thyroid carcinoma by targeting of Rac1. Neoplasma. 62:541–549.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fan M, Li X, Jiang W, Huang Y, Li J and
Wang Z: A long non-coding RNA, PTCSC3, as a tumor suppressor and a
target of miRNAs in thyroid cancer cells. Exp Ther Med.
5:1143–1146. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhao JJ, Hao S, Wang LL, Hu CY, Zhang S,
Guo LJ, Zhang G, Gao B, Jiang Y, Tian WG, et al: Long non-coding
RNA ANRIL promotes the invasion and metastasis of thyroid cancer
cells through TGF-β/Smad signaling pathway. Oncotarget.
7:57903–57918. 2016.PubMed/NCBI
|
|
27
|
Lee EK, Hong SH, Shin S, Lee HS, Lee JS,
Park EJ, Choi SS, Min JW, Park D, Hwang JA, et al: nc886, a
non-coding RNA and suppressor of PKR, exerts an oncogenic function
in thyroid cancer. Oncotarget. 7:75000–75012. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sun M, Liu XH, Wang KM, Nie FQ, Kong R,
Yang JS, Xia R, Xu TP, Jin FY, Liu ZJ, et al: Downregulation of
BRAF activated non-coding RNA is associated with poor prognosis for
non-small cell lung cancer and promotes metastasis by affecting
epithelial-mesenchymal transition. Mol Cancer. 13:682014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zheng H, Wang M, Jiang L, Chu H, Hu J,
Ning J, Li B, Wang D and Xu J: BRAF-activated long noncoding RNA
modulates papillary thyroid carcinoma cell proliferation through
regulating thyroid stimulating hormone receptor. Cancer Res Treat.
48:698–707. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dai M, Yuan F, Fu C and Shen G, Hu S and
Shen G: Relationship between epithelial cell adhesion molecule
(EpCAM) overexpression and gastric cancer patients: A systematic
review and meta-analysis. PLoS One. 12:e01753572017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zheng J, Zhao S, Yu X, Huang S and Liu HY:
Simultaneous targeting of CD44 and EpCAM with a bispecific aptamer
effectively inhibits intraperitoneal ovarian cancer growth.
Theranostics. 7:1373–1388. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gao S, Sun Y, Liu X, Zhang D and Yang X:
EpCAM and COX-2 expression are positively correlated in human
breast cancer. Mol Med Rep. 15:3755–3760. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Vieira GC, Chockalingam S, Melegh Z,
Greenhough A, Malik S, Szemes M, Park JH, Kaidi A, Zhou L,
Catchpoole D, et al: Correction: LGR5 regulates pro-survival
MEK/ERK and proliferative Wnt/β-catenin signalling in
neuroblastoma. Oncotarget. 8:323812017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lv Z, Yu JJ, Zhang WJ, Xiong L, Wang F, Li
LF, Zhou XL, Gao XY, Ding XF, Han L, et al: Expression and
functional regulation of stemness gene Lgr5 in esophageal squamous
cell carcinoma. Oncotarget. 8:26492–26504. 2017.PubMed/NCBI
|
|
35
|
Michelotti G, Jiang X, Sosa JA, Diehl AM
and Henderson BB: LGR5 is associated with tumor aggressiveness in
papillary thyroid cancer. Oncotarget. 6:34549–34560. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Saiselet M, Floor S, Tarabichi M, Dom G,
Hébrant A, van Staveren WC and Maenhaut C: Thyroid cancer cell
lines: An overview. Front Endocrinol (Lausanne).
3:1332012.PubMed/NCBI
|
|
37
|
Iacobas DA, Tuli NY, Iacobas S, Rasamny
JK, Moscatello A, Geliebter J and Tiwari RK: Gene master regulators
of papillary and anaplastic thyroid cancers. Oncotarget.
9:2410–2424. 2017.PubMed/NCBI
|
|
38
|
Fraser S, Go C, Aniss A, Sidhu S,
Delbridge L, Learoyd D, Clifton-Bligh R, Tacon L, Tsang V, Robinson
B, et al: BRAF(V600E) mutation is associated with decreased
disease-free survival in papillary thyroid cancer. World J Surg.
40:1618–1624. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Naito S, von Eschenbach AC, Giavazzi R and
Fidler IJ: Growth and metastasis of tumor cells isolated from a
human renal cell carcinoma implanted into different organs of nude
mice. Cancer Res. 46:4109–4115. 1986.PubMed/NCBI
|
